The investment bank, which also set a 12-month price target of $5 for the company's shares, said it anticipates a growing footprint for the HTG EdgeSeq system.
The Center of Individualized Diagnostic aims to bring genomic-based cancer diagnostics to Saudi Arabia.
The deal is still subject to other closing requirements including meeting a minimum tender condition.
Since it was established in 2002, the consortium has identified about 200 previously unknown IBD susceptibility loci.
Different clades of Salmonella enterica serovar Enteritidis are behind the self-limiting and invasive diseases the bacterium causes in different parts of the world.
In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.
The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.
An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.
In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.
This webinar will discuss a customized protocol for RNA sequencing that was developed enable focused RNAseq analysis of formalin-fixed paraffin-embedded biopsies for biomarker discovery in prostate cancer.